Role of c-Src activity in the regulation of gastric cancer cell migration.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 4067425)

Published in Oncol Rep on May 15, 2014

Authors

Yun Yang1, Zhi-Gang Bai1, Jie Yin1, Guo-Cong Wu1, Zhong-Tao Zhang1

Author Affiliations

1: Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Xuanwu, Beijing 100050, P.R. China.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol (2002) 6.37

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med (2001) 5.52

Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J Cell Biol (1994) 1.80

Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res (2006) 1.74

Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. EMBO J (1997) 1.69

Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol (2003) 1.39

PIKfyve regulation of endosome-linked pathways. Traffic (2009) 1.39

Clinicopathological features and treatment outcomes of metastatic tumors in the stomach. Surg Today (2013) 1.33

Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell Oncol (2007) 1.24

Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim Biophys Acta (2009) 1.23

Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition. Mol Cancer Ther (2010) 1.21

Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules. J Biol Chem (2009) 1.20

Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin. Biochemistry (2010) 1.14

Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol (2003) 1.12

Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. Cancer Res (2005) 1.10

Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer. PLoS One (2012) 1.06

Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer. Mol Cancer Ther (2012) 0.94

Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB. Eur J Pharm Sci (2011) 0.91

Direct sensing of endothelial oxidants by vascular endothelial growth factor receptor-2 and c-Src. PLoS One (2011) 0.89

Claudins and gastric carcinogenesis. Exp Biol Med (Maywood) (2013) 0.87

Src kinase and pancreatic cancer. Recent Results Cancer Res (2008) 0.83

Alterations in gene expression of proprotein convertases in human lung cancer have a limited number of scenarios. PLoS One (2013) 0.82

Neoplastic progression of the human breast cancer cell line G3S1 is associated with elevation of cytoskeletal dynamics and upregulation of MT1-MMP. Int J Oncol (2010) 0.82

Serum protein and genetic tumor markers of gastric carcinoma. Asian Pac J Cancer Prev (2013) 0.81

Proprotein convertase PC5 regulation by PDGF-BB involves PI3-kinase/p70(s6)-kinase activation in vascular smooth muscle cells. Hypertension (2002) 0.81

Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma. World J Surg Oncol (2013) 0.79

Proprotein convertase subtilisin/kexin type 3 promotes adipose tissue-driven macrophage chemotaxis and is increased in obesity. PLoS One (2013) 0.79